We're building the most advanced prescription intelligence platform in the world.
RxRevu™ is based on three years of efficacy research and seven years of study into the prescribing habits of doctors. It is the most comprehensive data source available today for analyzing the relative cost and quality of medications.
Carm is a entrepreneur and strategic leader with over 20 years of experience in startups focused around consumer and enterprise technology. His first web development and hosting company he started while in high school was eventually acquired in 2001. After finishing his degree in electrical engineering at Northeastern University in 2004, he went on to work for PlumVoice, an IVR and voice technology startup, where he ran their network operations. He later was asked to run product development at My Perfect Gig, a Northbridge and Commonwealth Venture start-up.
After two years as CTO at Reef Partners, where he ran the technology for a number of portfolio companies, he became CTO at Audiogon.com, the largest high end audio site in the world. He managed the transition of the core technology platform and team for growth. In 2013 he moved to Denver where he founded RxRevu™.
Kyle has nearly a decade of experience in the value chain of health care. A passions for impactful and purpose driven businesses has lead him to be on the leading edge of empowering healthcare consumers. Kyle has been a part of developing wellness strategies for some of the countries most innovative employers and lead product launches with some of the nationals largest payors. Director level experience at Principal Wellness Company (NYSE:PFG), WellTok, and Catapult Health give Kyle a unique prospective on the trajectory of healthcare. Kyle leads the payors strategy efforts for RxRevu™ and is committed to creating more connected and informed relationships between Consumers, Payors, and Providers.
Physician with 25 years of clinical experience. Created several disease management programs for health plans. Spent 7 years as medical director of America's largest physician and patient education company, (which is now called PatientPoint). Major role was to conduct focus groups of doctors and patients and determine why doctors prescribe what they prescribe, and what patients want. At RxRevu™ he translates this experience into a comprehensive data platform to reduce pharma costs for patients and payers.
Peregrin brings over 15 years of application development and start-up experience to the table and specializes in software development and product design. Peregrin is responsible for the overall platform and data infrastructure at RxRevu™. He has been able to collaborate closely with physicians and scientists, bridging the gap between technology and evidence-based medicine. He has been a key contributor to CDS Hooks, a standard for event-driven clinical decision support.
Working with industry professionals from across the country, and engineers from leading EMRs, he is bringing the power of big data and the agility of the web to the EMR experience. Through his experience in working with a variety of EMRs, including Epic, Cerner, Athena Health, and Avatar, he has used technology and 3rd party data to improve clinical outcomes and improve provider efficiency.
With nearly 20 years of experience, Aaron specializes in management of finance, governance, and strategic human resource functions for high-growth, venture backed start-up companies. He is currently the Co-Founder and CFO of Tech Elevator, a bootcamp teaching novices how to become computer programmers over a 14-week program, and the Managing Member of Gypsy Brewery, operating out of the former Leisy Bottling Works building.
Bruce is a business development leader with experience in creating and building software, services and healthcare IT businesses. His skills include strategic planning, marketing, strategic partnerships, go-to-market strategies and execution. He has a BS in mechanical engineering from Purdue University and an MBA from the Harvard Business School. Bruce brings practical wisdom to the team and helps to shape business strategy with sharp insights, every step of the way.
10+ years in Artificial Intelligence, Machine Learning, and advanced statistical techniques. Trent also has 15+ years of experience in full stack web application development and is an expert on the basis of human behavior with publications in top academic journals. Trent is responsible for the creation of the predictive analytics and statistical components of RxRevu™. His work is robust and is paving the way for a better understanding of medication efficacy.
Nic joined RxRevu™ after 4 years of career foundation at a Sealed Air Corporation subsidiary where he consulted, implemented, and managed supply chain QA IT solutions for elite organizations in pharmacy and medical device distribution. He provides leadership in market assessment, strategic partnerships, and implementation expertise that help drive the development of RxRevu™ products and go-to-market strategies. Nic recently completed his MBA in Finance and Health Sector Management from Arizona State University.
9+ years of software development experience, working full time at 5 startups and contracting at others. Trained as a software engineer and computer scientist at Colorado School of Mines. Experience in full stack development, with a focus on server-side development in Ruby/Ruby on Rails, Python, Java, Go and others. Experience working with large data systems, messaging systems, web systems, performance improvements, and machine learning. Experienced in managing and building teams in a fast-paced startup environment.
Wes is a scientist with 7 years of research experience in a vast array of topics, including: salmonella pathogenesis, human arterial aging, protein biochemistry, cancer stem cells, clinical trial design, and cardiovascular pharmacology. He developed novel heart failure therapeutics during his dissertation research at the University of Colorado-Anschutz Medical Campus. His passion for improving the way patient symptoms are managed with pharmacotherapy led him to join RxRevu™, with the goal of achieving personalized medicine both quantitatively and qualitatively. Wes earned his PhD in Pharmacology in September 2015 and joined the RxRevu™ team shortly after.
Susan has six years experience as an executive assistant. A graduate of Western Michigan University, Susan coordinates high-level partnerships and facilitates meetings and schedules for the team.
Attorney and scientist with over 10 years experience in medical and legal environments. Past work includes academic and private scientific research, counsel at a prestigious law firm, government and corporate general counsel positions. Daniel specializes in business strategy, intellectual property utilization, and contract negotiation and drafting. Daniel operates under the belief that every business relationship will thrive as long as both parties are properly aligned and incentivized. Daniel has a BS in Biochemistry from Wake Forest University and a JD from the University of Maryland and is currently barred in the State of Colorado.
Kelly is responsible for RxRevu™’s marketing and communications strategy. She has over a decade of experience in healthcare sales and marketing, management consulting and analytics. Her passion for health and wellness inspired her to join Paladina Health as an early-stage start-up, focused on delivering value-based, direct primary care services. At Paladina Health (owned by dialysis leader, DaVita), she deepened relationships with brokers, payers and C-level executives through strategic content development, product enhancement and value-focused marketing and business development initiatives. Prior to joining RxRevu™, Kelly led a Business Intelligence department focused on marketing analytics at a travel membership company.
Steve has founded/co-founded and invested in companies in healthcare devices, technology enabled services, digital media and enterprise software. He have served on numerous boards and participated in raising dozens of equity and debt financings from both venture capital and corporate sources.
He is a senior advisor to Triple Tree, a leading healthcare technology merchant bank and private equity firm. He is on the boards of Imagescan (transactional content management), Nucleus Health, (a leader in tele- radiology and related image sharing technology) and Cleveland Clinic Innovations, which oversees innovation commercialization for that institution. He is an advisor to Healthprize, (a prescription medication adherence company), Knowledge Factor, (a leader in neuroscience-based education), Cyft (a new tool to enable anyone to build predictive models), and Fitzroy Health, (building and advising tech-enabled healthcare companies). He is a consultant to Partners Healthcare (Mass. General and Brigham & Women's Hospitals), Mercy Health, Ariadne Labs and Anschutz Medical Campus/University of Colorado.
Prior ventures he has been a founding investor in include Dental Research Corp, maker of the Interplak Toothbrush (sold to Bausch & Lomb), Thermoscan, maker of the Thermoscan Thermometer (sold to Gillette), Complient, outsource provider of emergency medical response services (sold to Cardiac Science), Axentis, provider of compliance software for the pharmaceutical industry (sold to Wolters Kluwer), Explorys, clinical big data management (sold to IBM) and YouBeauty, a women's digital media wellness business (sold to Caivis Holdings).
Stephen has a 30-year career in founding, investing in and building information technology companies. He is recognized for his leadership in data mining, analytics and business intelligence related ventures. Stephen was Founder, lead investor and served as Chairman of the Board and Chief Executive Officer of Explorys. Formed in partnership with Cleveland Clinic, Explorys addresses the national imperative to leverage electronic medical records for the improvement of Healthcare. Explorys was acquired by IBM [NYSE: IBM] in April 2015. Prior to Explorys he served as the Chairman of the Board and CEO of Everstream, the company he founded in 1999 which was sold to Concurrent [NASDAQ: CCUR] in 2005. In 1985, Stephen founded McHale and Associates, Inc., a USConnect regional office, where he served as Chairman of the Board and CEO. He was a founding investor and served on the Board of Directors and as CEO of the parent USConnect, an international systems integrator until its sale to IKON Office Systems [NYSE: IKN] in 1997. Stephen is Managing Director of 23Bell LLC Investments and an active Advisory Board Member to Genesis Inventions.
Stephen serves on the Board of Directors for the Center for Families and Children, a non-profit organization that makes success possible for families in Northeast Ohio’s most challenged communities. Stephen serves on the investment screening committee for the North Coast Angel Fund and is a member of The Global Center for Health Innovation Industry Advisory Board. He is also an active member of the Entrepreneurs Organization and Kent State University’s Health Informatics Advisory Council.
Jeffrey Patton, M.D. serves as Chief Executive Officer and Chairman of the Board for Nashville-based Tennessee Oncology, one of the largest community oncology practices in the U.S.
He is nationally recognized in the oncology community for his extensive clinical trial research and scholarly publications on advancing cancer treatment and bringing exceptional care to the communities where patients live. Dr. Patton has published eight manuscripts and nearly 20 clinical trial abstracts on cancer treatment research. He specializes in all adult malignancies and holds memberships in the Tennessee Oncology Practice Society and the American Society of Clinical Oncology, where he serves on the ASCO Clinical Practice Committee.
Dr. Patton, a graduate of Eastern Virginia Medical School in Norfolk, completed his residency and fellowship at Wake Forest University in Winston-Salem, N.C., where he served as Chief Resident. He also holds a B.A. in Psychology from the University of Virginia. He currently serves as Chairman of the Southern Oncology Board of Directors and is on the board of directors for PearlPoint Cancer Support. He previously served as Chief of Staff for Southern Hills Medical Center and on the board of directors for the Sarah Cannon Research Institute.
Dr. Patton is also co-founder and Chief Medical Officer of Raintree Oncology Services, a provider of comprehensive oral drug acquisition and management services to help community oncology practices improve and advance patient care.
Healthcare Services/Healthcare Information Technology industry expertise and Technology Vision and Strategy Execution functional expertise.
Albert has worked with multiple Peloton Equity portfolio companies, including in deal diligence for HealthPlanOne, Inc. and Identity Theft Guard Solutions, Inc. Most significantly, Albert has served as the Chief Information and Chief Technology Officer for AeroCare Holdings, Inc. (Peloton I/FFC II), since 2014. At AeroCare, Albert is focused on technology operations, product development, and technology strategy. Prior to joining AeroCare, he served as an SVP at UnitedHealth Group, as CTO of the Optum Cloud. Prior to working with UnitedHealth, he served as CIO/CTO of Connextions Inc., a company that specialized in consumer driven healthcare solutions for payors, and was sold to Optum (a UnitedHealth Group company) in August of 2011 for approximately $350 million. Before Connextions, Albert was CIO of Rotech Medical Corporation, a publicly traded medical equipment company.
Albert is an active investor in healthcare and technology companies and and currently serves on the Board of Directors of NucleusHealth, MetisMachine, RxRevu™, HCF Enterprises and HCF Reality. Albert holds a B.A. from the University of Michigan and a M.B.A. from Rollins College
We're certified by the National Association of Boards of Pharmacy e-Advertiser program as a trusted health information resource. This allows us to advertise in Google search results to help people find our website.
1553 Platte St, Ste 202
Denver, CO 80202